Congress faces a critical vote to avert a prolonged shutdown, while newly released documents shed light on the Minneapolis shooting involving immigration officers and the Epstein case continues to reverberate.
Following the FDA's decision to remove the clinical hold on Intellia's Nex-Z hATTR-PN trial, analysts at Baird and H.C. Wainwright have significantly raised their price targets for the CRISPR gene-editing pioneer, citing reduced regulatory risk and a clearer path forward.
In Thailand's crucial northeast, a profound political realignment is underway. Farmers, disillusioned by unmet promises and economic hardship, are abandoning decades of party loyalty to back individual candidates, testing the foundations of the Shinawatra family's political machine ahead of pivotal elections.
Backed by a major U.S. government loan and a surge in private equity, USA Rare Earth is accelerating its domestic mining and manufacturing projects, positioning itself at the forefront of a critical national strategy.
With the House of Representatives adjourned until Monday, a partial government shutdown continues after the Senate's late-Friday passage of a stopgap spending package failed to meet the deadline for dozens of agencies.
Faced with the realities of modern warfare in Ukraine, NATO is fast-tracking innovation, creating an unprecedented opportunity for agile tech founders to access a once-closed defense market.
The planned acquisition of craft beverage distributor Point Blank by industry giant Columbia Distributing will result in the closure of two Oregon facilities and impact 177 workers, despite assurances of a 'seamless' transition for partners.
JPMorgan raises Edison International's price target to $66, citing model updates ahead of earnings. The utility giant, noted for its sustainable high-yield dividend, continues to benefit from California's electrification trends and regulated investment framework.
A major analyst upgrade, fueled by Nvidia's deepening investment and strategic alignment, projects significant upside for the AI cloud infrastructure leader CoreWeave, despite recent stock volatility.
This week's Big Tech earnings revealed a stark divide: companies using existing cash cows to fund AI ambitions versus those betting the farm on a future payoff. The market's patience for visionary spending is wearing thin, demanding concrete timelines and a path to profit.
St. Louis Fed President Alberto Musalem argues the current interest rate stance is appropriate, signaling a pause in the central bank's easing cycle unless the labor market weakens or inflation drops unexpectedly.
In a bold bid to reclaim semiconductor leadership, Intel is aggressively deploying ASML's next-generation lithography systems years ahead of rival TSMC. The 2026 timeline is critical for the chipmaker's turnaround plan.
As states finalize legislation before the 2026 elections, a conservative-leaning watchdog group highlights vulnerabilities in the voting system, pushing for reforms to curb foreign influence and clarify citizenship requirements for voters.
Lawmakers are negotiating a short-term deal to fund the Department of Homeland Security, aiming to avoid a partial government shutdown this weekend. The talks occur against the backdrop of heightened political pressure following recent violence in Minneapolis and a shift in the administration's enforcement rhetoric.
Pakistani security forces conducted targeted military operations in the restive southwestern Balochistan province, resulting in the deaths of 41 militants. The raids signal an escalation in ongoing efforts to curb insurgent activities in the region.
Proposed flat payment rates for 2027 by CMS intensify margin pressures on Medicare Advantage insurers like Clover Health, raising investor concerns about cost management and growth prospects in a tightening regulatory landscape.
Ciena's stock rose sharply following announcements that Telekom Srbija Group and Trans Pacific Networks will deploy its high-capacity optical solutions, highlighting the growing demand for AI-ready network infrastructure in critical global corridors.
Amidst a global push for reliable, carbon-free power, Centrus Energy Corp. (LEU) emerges as a critical supplier in the nuclear fuel chain. With its stock trading near backlog value and recent financial developments reducing execution risk, analysts see a clear path for growth, particularly as AI and data center energy demands surge.
Facing the looming patent expiration of key drugs Revlimid and Eliquis, Bristol-Myers Squibb is making a strategic pivot, acquiring Orbital Therapeutics for $1.5 billion to pioneer in vivo RNA therapies. This high-stakes move aims to redefine the company's growth in oncology and autoimmune diseases.
Alphabet's self-driving subsidiary Waymo has closed a massive $16 billion funding round, catapulting its valuation to $126 billion and signaling robust investor confidence in the future of autonomous vehicles.
